Search

Search Constraints

You searched for: Date 2013 Author/Creator Cohn, Allen L.

Search Results

1. Axitinib and/or bevacizumab with modified FOLFOX‐6 as first‐line therapy for metastatic colorectal cancer: A randomized phase 2 study. Issue 14 (19th April 2013)

2. Axitinib and/or bevacizumab with modified FOLFOX‐6 as first‐line therapy for metastatic colorectal cancer: A randomized phase 2 study. Issue 14 (19th April 2013)

3. TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer. Issue 24 (1st October 2013)

4. TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial. Issue 24 (1st October 2013)